Asavi presents inhibitors of HCV NS5B polymerase, HBV DNA polimerase and HIV-1 reverse transcriptase April 27, 2018
Patient recruitment ongoing in phase II/III trial of relatlimab plus nivolumab in melanoma April 27, 2018